1
|
Kaiser GG, Mucci NC, González V, Sánchez L, Parrón JA, Pérez MD, Calvo M, Aller JF, Hozbor FA, Mutto AA. Detection of recombinant human lactoferrin and lysozyme produced in a bitransgenic cow. J Dairy Sci 2017; 100:1605-1617. [PMID: 28109583 DOI: 10.3168/jds.2016-11173] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Accepted: 10/07/2016] [Indexed: 02/02/2023]
Abstract
Lactoferrin and lysozyme are 2 glycoproteins with great antimicrobial activity, being part of the nonspecific defensive system of human milk, though their use in commercial products is difficult because human milk is a limited source. Therefore, many investigations have been carried out to produce those proteins in biological systems, such as bacteria, yeasts, or plants. Mammals seem to be more suitable as expression systems for human proteins, however, especially for those that are glycosylated. In the present study, we developed a bicistronic commercial vector containing a goat β-casein promoter and an internal ribosome entry site fragment between the human lactoferrin and human lysozyme genes to allow the introduction of both genes into bovine adult fibroblasts in a single transfection. Embryos were obtained by somatic cell nuclear transfer, and, after 6 transferences to recipients, 3 pregnancies and 1 viable bitransgenic calf were obtained. The presence of the vector was confirmed by fluorescent in situ hybridization of skin cells. At 13 mo of life and after artificial induction of lactation, both recombinant proteins were found in the colostrum and milk of the bitransgenic calf. Human lactoferrin concentration in the colostrum was 0.0098 mg/mL and that in milk was 0.011 mg/mL; human lysozyme concentration in the colostrum was 0.0022 mg/mL and that in milk was 0.0024 mg/mL. The molar concentration of both human proteins revealed no differences in protein production of the internal ribosome entry site upstream and downstream protein. The enzymatic activity of lysozyme in the transgenic milk was comparable to that of human milk, being 6 and 10 times higher than that of bovine lysozyme present in milk. This work represents an important step to obtain multiple proteins or enhance single protein production by using animal pharming and fewer regulatory and antibiotic-resistant foreign sequences, allowing the design of humanized milk with added biological value for newborn nutrition and development. Transgenic animals can offer a unique opportunity to the dairy industry, providing starting materials suitable to develop specific products with high added value.
Collapse
Affiliation(s)
- Germán G Kaiser
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina.
| | - Nicolás C Mucci
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Vega González
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Lourdes Sánchez
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - José A Parrón
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - María D Pérez
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Miguel Calvo
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Juan F Aller
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Federico A Hozbor
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Adrián A Mutto
- Laboratorio Biotecnologías Aplicadas a la Reproducción y Mejoramiento Genético Animal, Instituto de Investigaciones Biotechnològicas-Instituto Tecnològico Chascomùs (IIB-INTECH), Universidad Nacional de San Martin-Consejo de Investigaciones Cientìficas y Tècnicas (CONICET), 1650 San Martin, Argentina
| |
Collapse
|
2
|
Niemann H, Halter R, Espanion G, Wrenzycki C, Herrmann D, Lemme E, Carnwath JW, Paul D. Expression of human blood clotting factor VIII (FVIII) constructs in the mammary gland of transgenic mice and sheep. J Anim Breed Genet 2011. [DOI: 10.1111/j.1439-0388.1996.tb00634.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Yen CH, Yang CK, Chen IC, Lin YS, Lin CS, Chu S, Tu CF. Expression of recombinant Hirudin in transgenic mice milk driven by the goat β-casein promoter. Biotechnol J 2008; 3:1067-77. [DOI: 10.1002/biot.200800069] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
4
|
Abstract
The mammary gland has an incredible level of organization and a remarkable ability to convert circulating nutrients into milk components. This review highlights four areas of high interest in the biology of milk synthesis where advances over the last quarter-century have resulted in new understanding or revealed new opportunities. First, advances in our understanding of the mechanisms of milk secretion has led to a substantial increase in our knowledge of the intracellular origin of lipid droplets and the identity and potential function of milk fat globule membrane proteins in milk-lipid secretion. Second, recent breakthroughs have advanced our understanding of the nutritional regulation of milk fat and highlighted the interrelations between dietary components, digestive processes in the rumen, and the regulation of mammary synthesis of milk fat. Third, nutritional quality is becoming increasingly important in food choices because of consumer awareness of the links between diet and health. The traditional nutritional value of milk and dairy products is well established, but recent discoveries have identified a number of "bioactive" components in milk with potential to improve human health. Finally, the concept of genetic engineering and the use of animals as "bioreactors" and the "pharming" of proteins not normally found in milk have gained recognition, with the dairy industry ideally suited to take advantage of advances in these areas.
Collapse
Affiliation(s)
- D E Bauman
- Department of Animal Science, Cornell University, Ithaca, NY 14853, USA.
| | | | | | | |
Collapse
|
5
|
Trott JF, Adams TE, Wilson M, Nicholas KR. Positive and negative regulatory elements in the late lactation protein-A gene promoter from the tammar wallaby (Macropus eugenii). ACTA ACUST UNITED AC 2005; 1728:65-76. [PMID: 15777715 DOI: 10.1016/j.bbaexp.2005.01.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2004] [Revised: 12/24/2004] [Accepted: 01/21/2005] [Indexed: 10/25/2022]
Abstract
Little is known about the regulation of the marsupial-specific late lactation protein-A (LLP-A) gene, first expressed at mid-lactation in the mammary gland of the tammar wallaby. A genomic clone of LLP-A was sequenced and shown to include seven exons. The LLP-A promoter region of 1969 bp ligated to a secreted alkaline phosphatase (SEAP) gene reporter was co-transfected into CHO-K1 cells with prolactin (PRL) receptor cDNA. Transfected cells cultured with insulin, cortisol and PRL did not secrete SEAP into media. Similarly, this construct was not expressed in the mammary gland of eight lines of transgenic mice. In contrast, when the LLP-A promoter region was reduced to 850 bp, the expression of the SEAP reporter in CHO-K1 cells was constitutive and PRL-independent, despite the presence of two low affinity Stat5 binding sites. The 1969 bp promoter was analyzed using nine serial deletions ligated to the SEAP gene. The expression of these constructs was PRL-independent. Five putative inhibitory elements were identified between -1969 and -1796, -1404 and -1184, -1184 and -992, -992 and -757, and -591 and -425, and a putative enhancer or core transcription element between -425 and-239. These studies indicate that the complex temporal regulation of the LLP-A gene involves elements in its 5'-regulatory region.
Collapse
Affiliation(s)
- Josephine F Trott
- Victorian Institute of Animal Science, Department of Molecular Biology and Genetics, 475 Mickleham Rd, Attwood, Victoria, 3049, Australia
| | | | | | | |
Collapse
|
6
|
Zhu X, Cheng J, Huang L, Gao J, Zhang ZT, Pak J, Wu XR. Renal tubule-specific expression and urinary secretion of human growth hormone: a kidney-based transgenic bioreactor growth. Transgenic Res 2003; 12:155-62. [PMID: 12739883 DOI: 10.1023/a:1022967505222] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Tissue-specific expression of human genes and secretion of human proteins into the body fluids in transgenic animals provides an important means of manufacturing large-quantity and high-quality pharmaceuticals. The present study demonstrates using transgenic mice that a 3.0 kb promoter of the mouse Tamm-Horsfall protein (THP, or uromodulin) gene directs the specific expression of human growth hormone (hGH) gene in the kidney followed by the secretion of hGH protein into the urine. hGH expression was detected in renal tubules that actively produce the THP, that is, the ascending limb of Henle's loop and distal convoluted tubules. Up to 500 ng/ml of hGH was detected in the urine, and this level remained constant throughout the 10-month observation period. hGH was also detectable in the stomach epithelium and serum in two of the transgenic lines, suggesting position-dependent effects of the transgene and leakage of hGH from the site of synthesis into the bloodstream, respectively. These results indicate that the 3.0 kb mouse THP promoter is primarily kidney-specific and can be used to convert kidney into a bioreactor in transgenic animals to produce recombinant proteins. Given the capacity of urine production independent of age, sex and lactation, the ease of urinary protein purification, and the potentially distinct machinery for post-translational modifications in the kidney epithelial cells, the kidney-based transgenic bioreactor may offer unique opportunities for producing certain complex pharmaceuticals.
Collapse
Affiliation(s)
- Xinhua Zhu
- Department of Urology, New York University School of Medicine, New York, NY 10016, USA
| | | | | | | | | | | | | |
Collapse
|
7
|
Hens JR, Amstutz MD, Schanbacher FL, Mather IH. Introduction of the human growth hormone gene into the guinea pig mammary gland by in vivo transfection promotes sustained expression of human growth hormone in the milk throughout lactation. BIOCHIMICA ET BIOPHYSICA ACTA 2000; 1523:161-71. [PMID: 11042380 DOI: 10.1016/s0304-4165(00)00117-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
We tested the feasibility of transfecting mammary tissue in vivo with an expression plasmid encoding the human growth hormone (hGH) gene, under the control of the cytomegalovirus promoter. Guinea pig mammary glands were transfected with plasmid DNA infused through the nipple canal and expression was monitored in control and transfected glands by radioimmunoassay of milk samples for hGH. Sustained expression of hGH throughout lactation was attained with a polyion transfection complex shown to be optimal for the transfection of bovine mammary cells, in vitro. However, contrary to expectations, hGH expression was consistently 5- to 10-fold higher when DEAE-dextran was used alone for transfection. Thus polyion complexes which are optimal for the transfection of cells in vitro may not be optimal in vivo. The highest concentrations of hGH in milk were obtained when glands were transfected within 3 days before parturition. This method may have application for studying the biological role or physical properties of recombinant proteins expressed in low quantities, or for investigating the regulation of gene promoters without the need to construct viral vectors or produce transgenic animals.
Collapse
Affiliation(s)
- J R Hens
- Department of Animal and Avian Sciences, University of Maryland, College Park 20742, USA
| | | | | | | |
Collapse
|
8
|
Abstract
During the past 20 years, there have been many impressive advances in a number of scientific disciplines that have led to the discovery and development of exciting new biotechnologies that offer the potential to improve productive efficiency of animal agriculture. Some technologies have been developed from advances made in our understanding of how the endocrine system regulates growth and lactation. This information then has been used to devise viable strategies that alter circulating hormone concentration(s) to enhance animal production and productive efficiency. The most notable success to date using this approach has been bovine somatotropin, which has been adopted for use in the dairy industry in certain countries. Advances in transgenic biology, gene therapy, "knock-out" gene technologies, and cloning may lead to other novel products/strategies that enhance productive efficiency. The purpose of this paper is to discuss what future strategies might emerge that will increase meat and milk production and the efficiency of these processes.
Collapse
Affiliation(s)
- T D Etherton
- Department of Dairy and Animal Science, The Pennsylvania State University, University Park 16802, USA.
| |
Collapse
|
9
|
Kim SJ, Yu DY, Han YM, Lee CS, Lee KK. Cloning of human genomic lactoferrin sequence and expression in the mammary glands of transgenic animals. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1998; 443:79-83. [PMID: 9781345 DOI: 10.1007/978-1-4757-9068-9_9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Affiliation(s)
- S J Kim
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, Taejon, Korea
| | | | | | | | | |
Collapse
|
10
|
Barber MC, Clegg RA, Travers MT, Vernon RG. Lipid metabolism in the lactating mammary gland. BIOCHIMICA ET BIOPHYSICA ACTA 1997; 1347:101-26. [PMID: 9295156 DOI: 10.1016/s0005-2760(97)00079-9] [Citation(s) in RCA: 188] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
11
|
Ruppert JM, Wright M, Rosenfeld M, Grushcow J, Bilbao G, Curiel DT, Strong TV. Gene therapy strategies for carcinoma of the breast. Breast Cancer Res Treat 1997; 44:93-114. [PMID: 9232269 DOI: 10.1023/a:1005761723853] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- J M Ruppert
- Department of Medicine, University of Alabama at Birmingham 35294-3300, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Uusi-Oukari M, Hyttinen JM, Korhonen VP, Västi A, Alhonen L, Jänne OA, Jänne J. Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice. Transgenic Res 1997; 6:75-84. [PMID: 9032980 DOI: 10.1023/a:1018461201385] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The generation is reported of transgenic mice expressing human granulocyte-macrophage colony-stimulating factor (GM-CSF) or human erythropoietin (EPO) under the control of bovine alpha s1-casein regulatory sequences. GM-CSF expression was specific to the mammary gland, and levels of human GM-CSF in transgenic mouse milk were in the range of mg ml-1. The specific activity of the milk GM-CSF was similar to that of the recombinant protein produced in Escherichia coli, and the glycosylation-derived size heterogeneity corresponded to that of the native human protein. In spite of the identical bovine regulatory sequences of the fusion genes, the levels of human EPO in transgenic mouse milk were 10(3)-10(6) times lower than those of GM-CSF, ranging from 0.003 to 3 micrograms ml-1. There appeared to be a positive correlation between the amount of EPO in the milk of lactating females and blood haematocrit values. In view of this, other type of constructs should be used to achieve more efficient EPO expression and to circumvent concomitantly-occurring adverse effects. In contrast, the high-level production of recombinant GM-CSF, its resemblance to the native mammalian protein, and mild adverse consequences of transgene expression imply that the current construct could be used for generation of larger GM-CSF transgenic animals to produce this protein in quantities sufficient for therapeutic purposes.
Collapse
Affiliation(s)
- M Uusi-Oukari
- Department of Physiology, University of Helsinki, Finland
| | | | | | | | | | | | | |
Collapse
|
13
|
KIM SJ, LEE KW, YU DY, HAN YM, LEE CS, NAM MS, MOON HB, LEE KK. Expression Analysis of a Bovine .BETA.-Casein/Human Lactoferrin Hybrid Gene in Transgenic Mice. J Reprod Dev 1997. [DOI: 10.1262/jrd.43.143] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Sun Jung KIM
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Ko-Woon LEE
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Dae-Yeul YU
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Yong-Mahn HAN
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Chul-Sang LEE
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Myung-Soo NAM
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| | - Hyung-Bae MOON
- Department of Pathology, School of Medicine, Wonkwang University, Iksan 570-749, Chonbuk, Korea
| | - Kyung-Kwang LEE
- Plant and Animal Cell Technology Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Taejon 305-333, Korea
| |
Collapse
|
14
|
Platenburg GJ, Vollebregt EJ, Karatzas CN, Kootwijk EP, De Boer HA, Strijker R. Mammary gland-specific hypomethylation of Hpa II sites flanking the bovine alpha S1-casein gene. Transgenic Res 1996; 5:421-31. [PMID: 8840525 DOI: 10.1007/bf01980207] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
In the lactating cow, mammary gland-specific hypomethylation occurs at two Hpa II sites in the 5'-flanking region of the alpha S1-casein gene, and one in the 3'-region. These sites, A, B and C, are at nucleotide position -1388, -774 and +18034, respectively, relative to the major transcription start site. Site B was hypomethylated when the alpha S1-casein gene was expressed, and methylated when not expressed. In transgenic mice containing the bovine alpha S1-casein 5' and 3' regulatory elements fused to the human lactoferrin (hLF) cDNA, in some cases similar methylation patterns of sites A and B, as compared to the situation in the cow, were observed. In five mouse lines (out of the seven analysed) expressing the transgene in the milk, site B was hypomethylated in the mammary gland, while it was methylated in liver. In the two other mouse lines, no correlation was found between transgene expression and mammary gland-specific hypomethylation of site B. One of the five mouse lines with transgene expression and showing mammary-gland-specific hypomethylation of site B was studied in detail. In this mouse line, induction of transgene expression preceded hypomethylation of site B.
Collapse
|
15
|
Bijvoet AG, Kroos MA, Pieper FR, de Boer HA, Reuser AJ, van der Ploeg AT, Verbeet MP. Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice. BIOCHIMICA ET BIOPHYSICA ACTA 1996; 1308:93-6. [PMID: 8764823 DOI: 10.1016/0167-4781(96)00093-0] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Enzyme replacement therapy is at present the option of choice for treatment of lysosomal storage diseases. To explore the feasibility of lysosomal enzyme production in milk of transgenic animals, the human acid alpha-glucosidase cDNA was placed under control of the alpha S1-casein promoter and expressed in mice. The milk contained recombinant enzyme at a concentration up to 1.5 micrograms/ml. Enzyme purified from milk of transgenic mice was internalized via the mannose 6-phosphate receptor and corrected enzyme deficiency in fibroblasts from patients. We conclude that transgenically produced human acid alpha-glucosidase meets the criteria for therapeutic application.
Collapse
Affiliation(s)
- A G Bijvoet
- Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
16
|
Archer JS, Kennan WS, Gould MN, Bremel RD. Human growth hormone (hGH) secretion in milk of goats after direct transfer of the hGH gene into the mammary gland by using replication-defective retrovirus vectors. Proc Natl Acad Sci U S A 1994; 91:6840-4. [PMID: 8041706 PMCID: PMC44293 DOI: 10.1073/pnas.91.15.6840] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Mammary-specific promoters have been used in transgenic animals to limit transgene expression to the mammary gland. Gene therapy techniques to target just one organ for introduction of a foreign gene have also been demonstrated. We have directly infused replication-defective retroviruses encoding hGH into the mammary gland of goats via the teat canal during a period of hormone-induced mammogenesis. This resulted in the secretion of hGH into the milk when lactation commenced on day 14 of the regime. Levels of hGH in the milk were highest on the first day of lactation, averaging approximately 60 ng/ml, and declined to a plateau of 12 ng/ml from day 9 to day 15 of lactation. Thus we report targeting of replication-defective retroviruses to the mammary secretory epithelial cells to produce foreign proteins in the milk of ruminants.
Collapse
Affiliation(s)
- J S Archer
- Department of Dairy Science, University of Wisconsin-Madison 53706
| | | | | | | |
Collapse
|
17
|
Barash I, Faerman A, Ratovitsky T, Puzis R, Nathan M, Hurwitz DR, Shani M. Ectopic expression of beta-lactoglobulin/human serum albumin fusion genes in transgenic mice: hormonal regulation and in situ localization. Transgenic Res 1994; 3:141-51. [PMID: 8025593 DOI: 10.1007/bf01973981] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We produced transgenic mice carrying the native sheep beta-lactoglobulin (BLG) or fusion genes composed of the BLG promoter and human serum albumin (HSA) minigenes. BLG was expressed exclusively in the mammary glands of the virgin and lactating transgenic mice evaluated. In contrast, transgenic females carrying the BLG/HSA fusion constructs also expressed the HSA RNA ectopically in skeletal muscle, kidney, brain, spleen, salivary gland and skin. Ectopic expression of HSA RNA was detected only in strains that express the transgene in the mammary gland. There was no obvious correlation between the level of the HSA RNA expressed in the mammary gland and that found ectopically. In three transgenic strains analysed, the expression of HSA RNA in kidney and skeletal muscle increased during pregnancy and lactation, whereas in the brain HSA expression decreased during lactation in one of the strains. HSA protein was synthesized in skeletal muscle and skin of strain #23 and its level was higher in lactating mice compared with virgin mice. Expression of HSA was also analysed in males and was found to be more stringently controlled than in females of the same strains. In situ hybridization analyses localized the expressed transgene in the skin, kidney, brain and salivary glands of various transgenic strains. Distinct strain-specific and cell-type specific HSA expression patterns were observed in the skin. This is in contrast to the exclusive expression of the HSA transgene in epithelial cells surrounding the alveoli of the mammary gland. Taken together, these results suggest that the absence of sufficient mammary-specific regulatory elements in the BLG promoter sequences and/or the juxtaposition of the BLG promoter with the HSA coding sequences leads to novel tissue- and cell-specific expression in ectopic tissues of transgenic mice.
Collapse
Affiliation(s)
- I Barash
- Institute of Animal Science, Volcani Center, Bet Dagan, Israel
| | | | | | | | | | | | | |
Collapse
|
18
|
Houdebine LM. [Expression of recombinant proteins in the milk of transgenic animals]. REVUE FRANCAISE DE TRANSFUSION ET D'HEMOBIOLOGIE : BULLETIN DE LA SOCIETE NATIONALE DE TRANSFUSION SANGUINE 1993; 36:49-72. [PMID: 8476491 DOI: 10.1016/s1140-4639(05)80168-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The bulky production of recombinant proteins can be achieved by procaryotes or eucaryotes cells. Cells from higher eucaryotes may be required when proteins have to be modified post-transcriptionally (glycosylation phosphorylation, cleavage, folding...). Cells from higher vertebrates in culture are used to prepare proteins like human factor VIII and erythropoietin. The use of transgenic organism has been suggested to reach the same goal. Indeed a whole living organism allows a very potent amplification, the number of cells involved in the biosynthesis of the recombinant proteins being very numerous and in the best metabolic conditions. Biological fluids (blood, milk, insect hemolymph, egg white...) and possibly organs from transgenic animals are a priori the best sources of recombinant proteins. Blood is abundant and it is a by-product of slaughter house. Its composition is relatively complex and the circulating recombinant proteins may heavily alter health of animals. Milk is very abundant, its composition is relatively simple, it is poor in proteolytic enzymes and it can be collected easily. Hemolymph from insects is relatively scarce. Egg white will be a possible source of recombinant proteins, when transgenesis has become more accessible in birds. Organs from transgenic animals should be solicited only when a particular cell type is required for the biosynthesis of the recombinant proteins. Milk appears therefore, presently, as the best source of recombinant proteins from transgenic animals. About 15 public and private laboratories try to use these techniques. They consist in preparing vectors containing regulatory regions of one of the milk proteins genes and the coding part (cDNA or gene) of the corresponding proteins to be produced. The transfer of these gene constructs to mouse, rabbit, sheep, goat, pig, shows that these techniques are indeed very promising. A single protein, human alpha 1-antitrypsin produced in milk of transgenic sheep, has presently reached the preparation at an industrial scale. This method has two theoretical limitations: 1) some of the proteins secreted in milk may be not matured as their native counterparts. Experiments carried out so far (about 20 proteins has been produced at an experimental scale) indicate that the mammary cell is able to achieve glycosylation in a correct way; 2) a significant proportion of the recombinant proteins migrate from the alveolar compartment of the mammary gland to blood circulation and they can alter health of lactating animals.(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
Affiliation(s)
- L M Houdebine
- Unité de Différenciation Cellulaire, Institut National de la Recherche Agronomique, Jouy-en-Josas
| |
Collapse
|